Advancing early detection during Head and Neck Cancer Awareness Month
April is Head and Neck Cancer Awareness Month, highlighting a diverse group of diseases that account for nearly 5% of all cancers in the United States.
Clinical Scorecard: Advancing early detection during Head and Neck Cancer Awareness Month
At a Glance
Category Detail
Condition Head and Neck Cancer Key Mechanisms Tobacco and alcohol use, high-risk HPV strains Target Population Patients at risk for head and neck cancers Care Setting National Cancer Institute-designated comprehensive cancer center
Key Highlights
Accounts for nearly 5% of all cancers in the U.S. Risk factors include tobacco, alcohol, and high-risk HPV Warning signs include persistent neck mass and nonhealing mouth sore UCI Health offers multidisciplinary care and advanced treatments Access to clinical trials and immunotherapy available Guideline-Based Recommendations
Diagnosis
Identify warning signs such as persistent neck mass and hoarseness Consider HPV testing in relevant cases Management
Utilize advanced surgical treatment options Implement transoral robotic surgery for HPV-related cancers Monitoring & Follow-up
Regular follow-ups for patients post-treatment Monitor for recurrence and treatment side effects Risks
Increased risk associated with tobacco and alcohol use Potential complications from advanced surgical procedures Patient & Prescribing Data
Patients diagnosed with head and neck cancers
Focus on multidisciplinary care and access to innovative therapies
Clinical Best Practices
Encourage early detection through awareness of warning signs Provide comprehensive care involving multiple specialties Facilitate access to clinical trials for eligible patients References
